Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.

Authors:
Perneel J; Rademakers R.

Journal:
Acta Neuropathol

Publication Year: 2022

DOI:
10.1007/s00401-022-02486-5

PMCID:
PMC9547799

PMID:
36056242

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Acta Neuropathol

Abbreviation: Acta Neuropathol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Neurology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Astroglial calcium signaling and homeostasis in tuberous sclerosis complex.
Romagnolo A; Dematteis G; Scheper M and 16 more (2024) - Transparency Score: 3/6
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and c…
Gödicke S; Kresbach C; Ehlert M and 14 more (2024) - Transparency Score: 3/6
Cortical matrix remodeling as a hallmark of relapsing-remitting neuroinflammation in MR elastograph…
Silva RV; Morr AS; Herthum H and 13 more (2024) - Transparency Score: 3/6
Cryptic exon inclusion is a molecular signature of LATE-NC in aging brains.
Chung M; Carter EK; Veire AM and 11 more (2024) - Transparency Score: 2/6
Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alz…
Agra Almeida Quadros AR; Li Z; Wang X and 27 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"J.P is supported by a fellowship from Research Foundation – Flanders (FWO, application 11M1622N). Dr. Rademakers is a member of the Scientific Advisory Board of Arkuda Therapeutics and receives invention royalties from a patent related to progranulin. Dr. Rademakers receives research support from the National Institutes of Health (NIH) and the Department of Defense (DOD). Figures were created with BioRender.com."

Evidence found in paper:

"J.P is supported by a fellowship from Research Foundation – Flanders (FWO, application 11M1622N). Dr. Rademakers is a member of the Scientific Advisory Board of Arkuda Therapeutics and receives invention royalties from a patent related to progranulin. Dr. Rademakers receives research support from the National Institutes of Health (NIH) and the Department of Defense (DOD). Figures were created with BioRender.com."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025